NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents

NIH RePORTER · NIH · N01 · $2,198,288 · view on reporter.nih.gov ↗

Abstract

The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of therapeutics and vaccines against diseases caused by pathogens that threaten public health such as, HIV, pandemic influenza, and emerging and re-emerging infectious diseases like Ebola, Zika, and Malaria.

Key facts

NIH application ID
10722428
Project number
75N91019D00024-P00006-759101900135-1
Recipient
LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator
CHRISTOPHER CASE
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$2,198,288
Award type
Project period
2019-09-30 → 2027-09-11